Having trouble viewing this email? View in your browser.

17 July 2018

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.


ESCMID/ASM Conference on Drug Development to meet the Challenge of Antimicrobial Resistance, Lisbon, 4-7 September 2018

Don’t miss the chance to register for this exciting update on the use of new drug therapies, as well as a look at the pipeline of upcoming antimicrobial agents.

Registrations at: escmid.pulselinks.com/event/17903

› Read more

CMI Highlight: HCV-genotype 1 NS5A RAVs and advanced liver fibrosis

Parczewski et al characterized the differences in NS3 and NS5A resistance-associated variants (RAVs) frequencies among therapy naļve genotype 1a and 1b (G1a, G1b) HCV mono-infected and HIV/HCV-coinfected patients (n=387) and their association with liver fibrosis.

› Read more

ESCMID Summer School in Paris

The ESCMID Summer School wrapped up in Paris last week, with 77 young professionals from over 30 countries meeting for comprehensive coverage of a variety of topics in Clinical Microbiology and Infectious Diseases, as well as an exciting social program.

› Read more

Postgraduate Education Course, Lausanne

The ESCMID Course 'Diagnostic Microbiology: MALDI-TOF, Bacterial Genomics, Metagenomics, Automation and Molecular Microbiology' is being held in Lausanne, Switzerland from 25-28 September, 2018. This course represents a fantastic opportunity for microbiologists and other diagnostic professionals to exchange knowledge and ideas on the present and future of diagnostic microbiology.

› Read more

Novartis Exits Antibiotics Research

Swiss drugmaker Novartis AG has announced that they will shut down antibacterial and antiviral research in the San Francisco Bay area.

› Read more

International Conference on Migration Health (ICMH) – ESCMID Grants

ESCMID is offering 9 attendance grants to the ICMH, to be held in Rome, Italy from 1 – 3 September. ESCMID members are eligible to apply for these grants, with preference for young scientists and students. Please send a 100 word motivational letter, along with student identification (if applicable) to info@escmid.org

› Read more

Register now for the 5th conference of the ESCMID Study Group for Legionella Infections

ESCMID Study Group for Legionella Infections (ESGLI) will be held in Lyon (France) on 28 - 30 August 2018. The conference will cover a wide range of topics related to Legionella and Legionnaires’ disease, from basic microbial genetics and pathogenesis to applied aspects of detection, control and management. Speakers will present the latest scientific developments in various sessions: Epidemiology and surveillance, Microbe – Environment interactions – Environmental detection, Genetics – Genomics, Host – Microbe interactions / Immunology, Legionella typing, Legionella prevention and control strategies. The conference will bring together fundamental and applied research professionals.

This conference is a valuable and unique opportunity to meet other members of the community of European experts in Legionella. Participation by students and scientists in the early stages of their careers  is greatly encouraged. 

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.